This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents. Top assignees: Beijing Konruns Pharmaceutical Co., Ltd., Beijing Wehand-Bio Pharmaceutical Co., Ltd, Guangxi Wehand-Bio Pharmaceutical Co., Ltd. Active years: 2025-2026.
Company Filing History:
1 out of 4 
1 out of 2 
1 out of 2 Years Active: 2025-2026
Title: The Innovations of Hongzhen Yang
Introduction
Hongzhen Yang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical technology. His work focuses on developing innovative solutions for treating diseases related to protein kinases AXL and VEGFR2.
Latest Patents
Hongzhen Yang holds a patent for a crystalline form of a compound, along with methods for preparing the same, pharmaceutical compositions, and their uses. The patent details three crystalline forms, namely crystalline form AB, crystalline form M, and crystalline form F, of the compound 6-[[4-[2-fluoro-4-[[1-[(4-fluorophenyl)aminoformyl]cyclopropanecarbonyl]-amino]phenoxy]-6-methoxy-7-quinolyl]oxy]hexanoic acid. These forms exhibit good chemical stability and are designed for the treatment of diseases associated with specific protein kinases. The preparation processes for these forms are straightforward, yielding high product purity and facilitating mass production.
Career Highlights
Hongzhen Yang is affiliated with Beijing Konruns Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the pharmaceutical industry.
Collaborations
He collaborates with notable colleagues, including Xiaohua Sun and Long Wang, to further enhance the impact of his research.
Conclusion
Hongzhen Yang's contributions to pharmaceutical technology exemplify the importance of innovation in addressing complex medical challenges. His patented work on crystalline forms of compounds showcases his commitment to advancing healthcare solutions.